Generic Plavix (clopidogrel) may not be here to stay
October 2006
Generic Plavix (clopidogrel) may not be here to stay.
Apotex is challenging a patent that's not due to expire until 2011. They think they have a good case, so they launched a generic BEFORE the case was resolved.
A few days later, Bristol-Myers and Sanofi got an injunction to stop sales of the generic until a final ruling is made.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote